Weik Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.66M Sell
19,044
-310
-2% -$72.2K 1.85% 14
2025
Q4
$4.01M Sell
19,354
-3,037
-14% -$601K 1.5% 21
2025
Q3
$4.15M Sell
22,391
-190
-0.8% -$32.6K 1.55% 20
2025
Q2
$3.45M Sell
22,581
-1,095
-5% -$168K 1.36% 21
2025
Q1
$3.93M Sell
23,676
-535
-2% -$83.7K 1.6% 18
2024
Q4
$3.5M Sell
24,211
-235
-1% -$36.4K 1.42% 22
2024
Q3
$3.96M Sell
24,446
-410
-2% -$65.3K 1.6% 19
2024
Q2
$3.63M Sell
24,856
-2,892
-10% -$430K 1.55% 19
2024
Q1
$4.39M Sell
27,748
-1,038
-4% -$165K 1.86% 15
2023
Q4
$4.51M Sell
28,786
-1,567
-5% -$240K 2.09% 12
2023
Q3
$4.73M Sell
30,353
-535
-2% -$88.3K 2.33% 11
2023
Q2
$5.11M Sell
30,888
-5,432
-15% -$877K 2.41% 11
2023
Q1
$5.63M Sell
36,320
-347
-0.9% -$56K 2.58% 9
2022
Q4
$6.48M Sell
36,667
-23
-0.1% -$3.97K 3.03% 8
2022
Q3
$5.99M Sell
36,690
-719
-2% -$122K 2.99% 8
2022
Q2
$6.64M Buy
37,409
+24
+0.1% +$4.28K 3.03% 8
2022
Q1
$6.63M Buy
37,385
+353
+1% +$60.1K 2.61% 8
2021
Q4
$6.33M Buy
37,032
+59
+0.2% +$9.66K 2.4% 9
2021
Q3
$5.97M Sell
36,973
-1,883
-5% -$321K 2.47% 10
2021
Q2
$6.4M Buy
38,856
+294
+0.8% +$48.7K 2.49% 10
2021
Q1
$6.34M Sell
38,562
-2
-0% -$324 2.69% 9
2020
Q4
$6.07M Sell
38,564
-336
-0.9% -$49.6K 2.72% 8
2020
Q3
$5.79M Sell
38,900
-241
-0.6% -$35.7K 2.83% 8
2020
Q2
$5.5M Sell
39,141
-1,540
-4% -$224K 2.97% 7
2020
Q1
$5.33M Sell
40,681
-517
-1% -$73.3K 3.04% 7
2019
Q4
$6.01M Sell
41,198
-730
-2% -$99K 2.71% 8
2019
Q3
$5.42M Sell
41,928
-2,006
-5% -$264K 2.6% 10
2019
Q2
$6.12M Sell
43,934
-1,447
-3% -$200K 2.93% 7
2019
Q1
$6.34M Sell
45,381
-217
-0.5% -$29.1K 3.09% 6
2018
Q4
$5.88M Sell
45,598
-348
-0.8% -$48.5K 3.2% 6
2018
Q3
$6.35M Sell
45,946
-202
-0.4% -$26.8K 3.05% 6
2018
Q2
$5.6M Buy
46,148
+2,136
+5% +$266K 2.75% 10
2018
Q1
$5.64M Buy
44,012
+4,805
+12% +$649K 2.71% 7
2017
Q4
$5.48M Sell
39,207
-29
-0.1% -$4.04K 2.56% 10
2017
Q3
$5.1M Sell
39,236
-303
-0.8% -$40.2K 2.43% 11
2017
Q2
$5.23M Sell
39,539
-378
-0.9% -$48.2K 2.76% 8
2017
Q1
$4.97M Sell
39,917
-229
-0.6% -$27.4K 2.64% 8
2016
Q4
$4.63M Sell
40,146
-526
-1% -$60.8K 2.59% 9
2016
Q3
$4.8M Buy
40,672
+48
+0.1% +$5.82K 2.76% 7
2016
Q2
$4.93M Sell
40,624
-717
-2% -$81.5K 2.95% 7
2016
Q1
$4.47M Sell
41,341
-701
-2% -$72.6K 2.69% 9
2015
Q4
$4.32M Sell
42,042
-176
-0.4% -$17.7K 2.6% 10
2015
Q3
$3.94M Sell
42,218
-1,083
-3% -$105K 2.4% 12
2015
Q2
$4.22M Sell
43,301
-25
-0.1% -$2.5K 2.44% 12
2015
Q1
$4.36M Sell
43,326
-552
-1% -$56.1K 2.53% 11
2014
Q4
$4.59M Sell
43,878
-93
-0.2% -$9.8K 2.66% 12
2014
Q3
$4.69M Sell
43,971
-654
-1% -$67.8K 2.88% 8
2014
Q2
$4.67M Sell
44,625
-158
-0.4% -$16K 2.86% 10
2014
Q1
$4.4M Sell
44,783
-5
-0% -$464 2.77% 9
2013
Q4
$4.1M Buy
44,788
+22
+0% +$2.03K 2.53% 12
2013
Q3
$3.88M Sell
44,766
-102
-0.2% -$9.15K 2.6% 9
2013
Q2
$3.85M Buy
+44,868
New +$3.81M 2.71% 10

Other funds holding JNJ

Weik Capital Management's JNJ Position: Q1 2026 in Review

Weik Capital Management reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2026, selling an estimated $72.2K and leaving 19,044 shares worth $4.66M. The position accounts for 1.85% of the portfolio, ranked #14.

Weik Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.64M in Q2 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Weik Capital Management held 19,044 shares of Johnson & Johnson worth $4.66M as of Q1 2026.
  • Weik Capital Management sold 310 Johnson & Johnson shares in Q1 2026, an estimated $72.2K.
  • Johnson & Johnson made up 1.85% of Weik Capital Management's portfolio in Q1 2026, its #14 holding.
  • Weik Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Weik Capital Management's Johnson & Johnson position peaked at $6.64M in Q2 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Weik Capital Management's 13F filing for Q1 2026, filed 12 May 2026.